Zolgensma (onasemnogene abeparvovec-xxxx) to receive priority review by FDA as a one-time treatment of type 1 spinal muscular atrophy (SMA).

Seeking a China Business Development and Support Manager with Mandarin working proficiency to join our team in Amsterdam.

Australia provides reimbursement for cystic fibrosis medicine.

The European Commission has approved Alunbrig (brigatinib) for the treatment of a specific type of lung cancer.

In an exploratory study Ocrevus (ocrelizumab) slowed down loss of function in the upper extremities for patients with primary progressive multiple sclerosis (PPMS).

A late-stage study testing Bavencio (avelumab) has failed to meet its primary endpoints in patients with certain forms of ovarian cancer.

Seeking an experienced and skilled Procurement and Supplier Manager to join our rapidly growing international team. 

 

Doctors hold the key to access new medicines.

How we find and ship medicines on behalf of patients.

8 modern tips and tricks for online safety.